Related Experiment Video
Updated: May 30, 2025
Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
Epigenetic modulation rescues neurodevelopmental deficits in Syngap1+/- mice
Akash Kumar Singh1,2, Ila Joshi1, Neeharika M N Reddy2
1Molecular Biology and Genetics Unit, Transcription and Disease Laboratory, Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru, India.
Researchers found that targeting epigenetic modifications with CSP-TTK21 reversed autistic behaviors and neural deficits in Syngap1+/- mice. This treatment restored synaptic function and improved neurogenesis, offering a potential therapeutic avenue for intellectual disability and autism spectrum disorder.
Area of Science:
- Neuroscience
- Epigenetics
- Developmental Biology
Background:
- SYNGAP1 mutations are linked to intellectual disability (ID) and autism spectrum disorder (ASD), affecting brain development and synaptic plasticity.
- Neurophysiological deficits in SYNGAP1 mutations are known, but the epigenetic landscape remains largely unexplored.
- Reduced histone acetylation marks were observed in the hippocampus of adolescent Syngap1+/- mice, correlating with impaired neurogenesis.
Purpose of the Study:
- To investigate the epigenetic alterations in SYNGAP1 mutation-mediated intellectual disability.
- To explore the therapeutic potential of modulating histone acetylation in a mouse model of SYNGAP1 deficiency.
- To establish a causal link between SYNGAP1 phenotype and altered histone acetylation.
Main Methods:
- Treatment of adolescent Syngap1+/- mice with CSP-TTK21, a p300/CBP activator.
- Assessment of histone acetylation marks, dendritic branching of neuroblasts (DCX+ neurons), synaptic function, and cortical circuit reorganization.
- Hippocampal RNA-Seq analysis to evaluate gene expression changes.
Main Results:
- CSP-TTK21 treatment enhanced p300/CBP-specific histone acetylation marks.
- Restored synaptic functions, increased dendritic branching of DCX+ neurons, and improved sensory-driven cortical plasticity.
- Reversed gene expression of key regulators of synaptic plasticity and neurogenesis (e.g., Adcy1, Ntrk3, Egr1, Foxj1).
Conclusions:
- Modulating histone acetylation with CSP-TTK21 can reverse key neurodevelopmental deficits associated with SYNGAP1 mutations.
- This study provides the first evidence for reversing autistic behavior and neural wiring through epigenetic modification.
- Targeting epigenetic dysregulation offers a promising therapeutic strategy for ID and ASD.
